Noxopharm Limited 32 Note 5. Expenses Consolidated 2022 2021 $ $ Loss before income tax includes the following specific expenses: Corporate Administration expenses Corporate administration expenses 708,363 404,205 Audit, accounting and company secretarial fees 155,321 253,802 Insurances 651,205 545,636 Legal fees 82,047 218,810 ASX and filing fees 67,677 171,314 Marketing and advertising 104,488 128,859 1,769,101 1,722,626 Consulting, Employee and Director Expenses Consulting expenses 280,523 389,993 Employee related expenses 3,711,154 3,122,666 Superannuation and other employee related expenses 437,419 258,740 Director expenses (excluding executive directors) 167,045 161,250 Share-based payment expense - Noxopharm Limited 803,511 1,742,043 5,399,652 5,674,692 Finance costs Interest and finance charges paid/payable 77,335 2,198,505 Fair value movement in derivative liability - 477,524 Finance costs expensed 77,335 2,676,029
RkJQdWJsaXNoZXIy MjE2NDg3